99 related articles for article (PubMed ID: 23747515)
1. Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer.
Fan NJ; Li K; Liu QY; Wang XL; Hu L; Li JT; Gao CF
Clin Biochem; 2013 Oct; 46(15):1578-84. PubMed ID: 23747515
[TBL] [Abstract][Full Text] [Related]
2. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
Fan NJ; Gao CF; Wang XL
OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
[TBL] [Abstract][Full Text] [Related]
3. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.
Fan NJ; Kang R; Ge XY; Li M; Liu Y; Chen HM; Gao CF
Diagn Pathol; 2014 Mar; 9():53. PubMed ID: 24618180
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.
Song D; Yue L; Li H; Zhang J; Yan Z; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
Br J Cancer; 2016 Apr; 114(8):929-38. PubMed ID: 27002935
[TBL] [Abstract][Full Text] [Related]
6. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
[TBL] [Abstract][Full Text] [Related]
7. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
8. Serum peptide mapping in gastric precancerous lesion and cancer.
Li P; Ma D; Zhu ST; Tang XD; Zhang ST
J Dig Dis; 2014 May; 15(5):239-45. PubMed ID: 24438315
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
10. Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis.
Liu XX; Ye H; Wang P; Zhang Y; Zhang JY
Mol Med Rep; 2017 Nov; 16(5):7759-7765. PubMed ID: 28944820
[TBL] [Abstract][Full Text] [Related]
11. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
12. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.
Yang J; Xiong X; Wang X; Guo B; He K; Huang C
Tumour Biol; 2015 Jul; 36(7):5109-18. PubMed ID: 25677901
[TBL] [Abstract][Full Text] [Related]
13. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
Beeharry MK; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
[TBL] [Abstract][Full Text] [Related]
14. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
15. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation.
Ren H; Du N; Liu G; Hu HT; Tian W; Deng ZP; Shi JS
World J Gastroenterol; 2006 May; 12(17):2789-92. PubMed ID: 16718772
[TBL] [Abstract][Full Text] [Related]
16. From proteomic multimarker profiling to interesting proteins: thymosin-β(4) and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions.
Henkel C; Schwamborn K; Zimmermann HW; Tacke F; Kühnen E; Odenthal M; Groseclose MR; Caprioli RM; Weiskirchen R
J Cell Mol Med; 2011 Oct; 15(10):2176-88. PubMed ID: 21496200
[TBL] [Abstract][Full Text] [Related]
17. Discovery of gastric cancer specific biomarkers by the application of serum proteomics.
Yoo MW; Park J; Han HS; Yun YM; Kang JW; Choi DY; Lee JW; Jung JH; Lee KY; Kim KP
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28133907
[TBL] [Abstract][Full Text] [Related]
18. Absence of beta-tubulin gene mutation in gastric carcinoma.
Urano N; Fujiwara Y; Hasegawa S; Miyoshi Y; Noguchi S; Takiguchi S; Yasuda T; Yano M; Monden M
Gastric Cancer; 2003; 6(2):108-12. PubMed ID: 12861402
[TBL] [Abstract][Full Text] [Related]
19. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].
Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180
[TBL] [Abstract][Full Text] [Related]
20. In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms.
Rebours V; Le Faouder J; Laouirem S; Mebarki M; Albuquerque M; Camadro JM; Léger T; Ruszniewski P; Lévy P; Paradis V; Bedossa P; Couvelard A
Pancreatology; 2014; 14(2):117-24. PubMed ID: 24650966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
